Walker Family Cancer Centre ,Niagara Health - St. Catharines Site
Welcome,         Profile    Billing    Logout  
 4 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tsakiridis, Theodoros
PATRON, NCT04557501: PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

Active, not recruiting
3
800
Canada
PSMA PET/CT guided intensification of therapy, Control Arm
Centre hospitalier de l'Université de Montréal (CHUM), Canadian Cancer Society (CCS), Lantheus Medical Imaging, British Columbia Cancer Agency, London Health Sciences Centre, Princess Margaret Hospital, Canada, Tom Baker Cancer Centre, McMaster University, Institute of Health Economics, Canada, Queen's University
Prostate Cancer
01/29
01/29
NCT02685397: Management of Castration-Resistant Prostate Cancer with Oligometastases

Active, not recruiting
2/3
102
Canada
Leuprolide Acetate, Eligard, Lupron, Goserelin Acetate, ZOLADEX, Triptorelin, Trelstar, Enzalutamide, Xtandi, Stereotactic Body Radiation Therapy, SBRT
Sir Mortimer B. Davis - Jewish General Hospital
Castration-resistant Prostate Cancer Patients with Oligometastases
04/27
08/41
NRG-LU001, NCT02186847: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Active, not recruiting
2
170
Canada, US, RoW
Radiation Therapy, 3-dimensional conformal radiation therapy, 3D-CRT, Intensity-modulated radiation therapy, IMRT, Carboplatin, Metformin, Metformin HCL, Metformin Hydrochloride, Paclitaxel
NRG Oncology, National Cancer Institute (NCI)
Adenosquamous Lung Carcinoma, Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Carcinoma, Recurrent Non-Small Cell Lung Carcinoma, Squamous Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer
04/19
04/25

Download Options